TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

Stock Information for TriSalus Life Sciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TriSalus Life Sciences Inc.

TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
TriSalus Life Sciences Announces Key Appointments to Board of Directors
TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.